cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs LIDE Biotech

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAxcelead Drug Discovery Partners, Inc.LIDE Biotech
SummaryAxcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Biomarker Assays
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Genomics & Sequencing Services
  • Proteomics Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Peptide
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Nephrology
  • Oncology
  • Immunology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, China
CertificationsData not yet provided.
  • AAALAC · Identifier: AAALAC accredited

Find similar companies

Axcelead Drug Discovery Partners, Inc. alternatives · LIDE Biotech alternatives

Markdown mirror: /compare/axcelead/lide-biotech.md